Search Prime Grants

70NANB21H085

Cooperative Agreement

Overview

Grant Description
Niimbl research, development, and testbeds to help the nation prevent, prepare for, and respond to coronavirus.
Awardee
University Of Delaware
Grant Program (CFDA)
11.619 - Arrangements for Interdisciplinary Research Infrastructure
Awarding / Funding Agency
National Institute of Standards and Technology (NIST) [DOC]
Place of Performance
Newark, Delaware 19716-0099 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the End Date has been extended from 06/30/24 to 06/30/25.
University Of Delaware was awarded COVID-19 Research Development Testbeds Biopharmaceutical Manufacturing Cooperative Agreement 70NANB21H085 worth $83,000,000 from the National Institute of Standards and Technology in July 2021 with work to be completed primarily in Newark Delaware United States. The grant has a duration of 4 years and was awarded through assistance program 11.619 Arrangements for Interdisciplinary Research Infrastructure.

Status
(Complete)

Last Modified 6/7/24

Period of Performance
7/1/21
Start Date
6/30/25
End Date
100% Complete

Funding Split
$83.0M
Federal Obligation
$0.0
Non-Federal Obligation
$83.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to 70NANB21H085

Subgrant Awards

Disclosed subgrants for 70NANB21H085

Transaction History

Modifications to 70NANB21H085

Additional Detail

Award ID FAIN
70NANB21H085
SAI Number
70NANB21H085_4
Award ID URI
EXE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
1333ND DEPT OF COMMERCE NIST
Funding Office
1333ND DEPT OF COMMERCE NIST
Awardee UEI
T72NHKM259N3
Awardee CAGE
015X1
Performance District
DE-00
Senators
Thomas Carper
Christopher Coons
Modified: 6/7/24